Design and synthesis of potent, non-peptidic inhibitors of HPTPβ

被引：33
|
作者：
Amarasinghe, Kande K. D.
Evidokimov, Artem G.
Xu, Kevin
Clark, Cynthia M.
Maier, Matthew B.
Srivastava, Anil
Colson, Anny-Odile
Gerwe, Gina S.
Stake, George E.
Howard, Brian W.
Pokross, Matthew E.
Gray, Jeffrey L.
Peters, Kevin G.
机构：
[1] Procter & Gamble Pharmaceut, Hlth Care Res Ctr, Mason, OH 45040 USA
[2] Chembiotek Res Inst, Kolkata 700091, W Bengal, India
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2006年 / 16卷 / 16期
关键词：
protein tyrosine phosphatases; HPTP beta; sulfamic acid; malonates; oxadiazoles; PROTEIN-TYROSINE PHOSPHATASES; ENDOTHELIAL GROWTH-FACTOR; ANGIOPOIETIN-1;
D O I：
10.1016/j.bmcl.2006.05.074
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
The sulfamic acid phosphotyrosine mimetic was coupled with a previously known malonate template to obtain highly selective and potent inhibitors of HPTP beta. Potentially hydrolyzable malonate ester functionalities were replaced with 1,2,4-oxadiazoles without a significant effect on HPTP beta potency. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码：4252 / 4256
页数：5
相关论文
共 50 条
  • [31] Highly potent non-peptidic inhibitors of the HCVNS3/NS4A serine protease
    Sperandio, D
    Gangloff, AR
    Litvak, J
    Goldsmith, R
    Hataye, JM
    Wang, VR
    Shelton, EJ
    Elrod, K
    Janc, JW
    Clark, JM
    Rice, K
    Weinheimer, S
    Yeung, KS
    Meanwell, NA
    Hernandez, D
    Staab, AJ
    Venables, BL
    Spencer, JR
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (21) : 3129 - 3133
  • [32] Rational hopping of a peptidic scaffold into non-peptidic scaffolds: structurally novel potent proteasome inhibitors derived from a natural product, belactosin A
    Kawamura, Shuhei
    Unno, Yuka
    Hirokawa, Takatsugu
    Asai, Akira
    Arisawa, Mitsuhiro
    Shuto, Satoshi
    CHEMICAL COMMUNICATIONS, 2014, 50 (19) : 2445 - 2447
  • [33] Non-peptidic natural products as ubiquitin-proteasome inhibitors
    Sengupta, Saumitra
    Mehta, Goverdhan
    TETRAHEDRON, 2019, 75 (07) : 817 - 853
  • [34] Hydantoin derivatives as non-peptidic inhibitors of Ras farnesyl transferase
    Lee, J
    Kim, J
    Koh, JS
    Chung, HH
    Kim, KH
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (07) : 1954 - 1956
  • [35] How to design cell permeable non-peptidic macrocycles
    Over, Bjorn
    Matsson, Par
    Tyrchan, Christian
    Artursson, Per
    Doak, Bradley
    Foley, Michael
    Hilgendorf, Constanze
    Johnston, Stephen
    Lee, Maurice
    Lewis, Richard
    McCarren, Patrick
    Muncipinto, Giovanni
    Perry, Matthew
    Duvall, Jeremy
    Kihlberg, Jan
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
  • [36] Investigations into small molecule non-peptidic inhibitors of the botulinum neurotoxins
    Capkova, Katerina
    Salzameda, Nicholas T.
    Janda, Kim D.
    TOXICON, 2009, 54 (05) : 575 - 582
  • [37] Non-peptidic inhibitors of insulin-regulated aminopeptidase (IRAP)
    Savmarker, Jonas
    Borhade, Sanjay
    Lundback, Thomas
    Chai, Siew
    Hallberg, Mathias
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
  • [38] Comparative molecular field analysis of non-peptidic inhibitors of thrombin
    Han, XF
    Liu, Y
    Gao, Y
    Lai, LH
    ACTA CHIMICA SINICA, 2003, 61 (07) : 1136 - 1139
  • [39] Synthesis and biological evaluation of non-peptidic cyclophilin ligands
    Wu, YQ
    Belyakov, S
    Choi, C
    Limburg, D
    Thomas, BE
    Vaal, M
    Wei, L
    Wilkinson, DE
    Holmes, A
    Fuller, M
    McCormick, J
    Connolly, M
    Moeller, T
    Steiner, J
    Hamilton, GS
    JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (07) : 1112 - 1115
  • [40] Design and bioassay of non-peptidic inhibitors of SARS coronavirus 3C-like proteinase
    Liu Ying
    Zheng Teng-Fei
    Jin Feng
    Zhou Lu
    Liu Zhen-Ming
    Wei Ping
    Lai Lu-Hua
    ACTA CHIMICA SINICA, 2007, 65 (16) : 1707 - 1712
12345